Network Pharmacology and Molecular Docking to Explore the Mechanism of Kangxian Decoction for Epilepsy

Table 2

Details of KEGG enrichment analysis.

ID	Description	value	Gene ID
hsa05219	Bladder cancer	9.18E-05	ERBB2 MMP9 CXCL8
hsa04657	IL-17 signaling pathway	0.001072	PTGS2 MMP9 CXCL8
hsa04071	Sphingolipid signaling pathway	0.002116	ADORA3 ASAH1 S1PR5
hsa05206	MicroRNAs in cancer	0.00413	CDC25B ERBB2 PTGS2 MMP9
hsa04913	Ovarian steroidogenesis	0.00552	PTGS2 AKR1C3
hsa04080	Neuroactive ligand-receptor interaction	0.007162	PTGER2 PTGDR ADORA3 S1PR5
hsa00590	Arachidonic acid metabolism	0.007821	PTGS2 AKR1C3
hsa05163	Human cytomegalovirus infection	0.012503	PTGER2 PTGS2 CXCL8
hsa05215	Prostate cancer	0.018985	ERBB2 MMP9
hsa01522	Endocrine resistance	0.019356	ERBB2 MMP9
hsa05146	Amoebiasis	0.020867	ARG1 CXCL8
hsa04064	NF-kappa B signaling pathway	0.021642	PTGS2 CXCL8
hsa04668	TNF signaling pathway	0.024856	PTGS2 MMP9
hsa04010	MAPK signaling pathway	0.025435	CDC25B ERBB2 CACNA2D2
hsa04670	Leukocyte transendothelial migration	0.025689	ITK MMP9
hsa04936	Alcoholic liver disease	0.038502	CPT1B CXCL8
hsa04921	Oxytocin signaling pathway	0.044611	CACNA2D2 PTGS2
hsa00220	Arginine biosynthesis	0.047584	ARG1
hsa05161	Hepatitis B	0.048873	MMP9 CXCL8